Barry Labinger Insider Profile
4 Followers
Barry Labinger, EVP, Biosciences Div. at Emergent Biosolutions, holds 25.18K shares in Emergent Biosolutions (Ticker: EBS), holds ― shares in Checkmate Pharmaceuticals (Ticker: CMPI). Most recently, Barry Labinger Sold ― shares of Emergent Biosolutions on Nov 17, 2015 for an estimated value of $123.22K.
Barry Labinger's Trading History
| EBSEmergent Biosolutions | Nov 17, 2015 | EVP, Biosciences Div. | Informative Sell | 123.22K | $145.80K | |
| CMPICheckmate Pharmaceuticals | ― | ― | ― | ― |
You May Also Like
Barry Labinger insider profile FAQ
What is the percentage of profitable transactions made by Barry Labinger?
The percentage of profitable transactions made by Barry Labinger is 100%.
What is the average return per transaction made by Barry Labinger?
The average return per transaction made by Barry Labinger is 11.70%.
What stocks does Barry Labinger hold?
Barry Labinger holds: EBS, CMPI stocks.
What was Barry Labinger’s latest transaction?
Barry Labinger’s latest transaction was an Informative Sell of $123.22K.
What was Barry Labinger's most profitable transaction?
Barry Labinger’s most profitable transaction was an Informative Sell of EBS stock on November 17, 2015. The return on the trade was 13.00%.
What is Barry Labinger's role in Emergent Biosolutions?
Barry Labinger's role in Emergent Biosolutions is EVP, Biosciences Div..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
